Selected research
Industry Research
Immunity Nutraceutical Ingredient Industry Research Report 2026
Market perspective
The global Immunity Nutraceutical Ingredient market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Immunity Nutraceutical Ingredient is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Immunity Nutraceutical Ingredient is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Immunity Nutraceutical Ingredient include Tate & Lyle PLC (U.K), Koninklijke DSM N.V. (Netherlands), Ingredion Incorporated (U.S), Arla Foods (Denmark) and Ajinomoto Co., Inc. (Japan), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Immunity Nutraceutical Ingredient market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immunity Nutraceutical Ingredient Market by Company
Tate & Lyle PLC (U.K)
Koninklijke DSM N.V. (Netherlands)
Ingredion Incorporated (U.S)
Arla Foods (Denmark)
Ajinomoto Co., Inc. (Japan)
Immunity Nutraceutical Ingredient Segment by Type
Carotenoids
Minerals
Omega-3 fatty acids
Fibers & specialty carbohydrates
Phytochemical and plant extracts
Others
Immunity Nutraceutical Ingredient Segment by Application
Dietary supplements
Functional beverages
Functional food
Personal care
Animal nutrition
Immunity Nutraceutical Ingredient Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunity Nutraceutical Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunity Nutraceutical Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunity Nutraceutical Ingredient.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Immunity Nutraceutical Ingredient manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Immunity Nutraceutical Ingredient by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Immunity Nutraceutical Ingredient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Carotenoids
- Minerals
- Omega-3 fatty acids
- Fibers & specialty carbohydrates
- Phytochemical and plant extracts
- Others
Applications
- Dietary supplements
- Functional beverages
- Functional food
- Personal care
- Animal nutrition
Companies covered
- Tate & Lyle PLC (U.K)
- Koninklijke DSM N.V. (Netherlands)
- Ingredion Incorporated (U.S)
- Arla Foods (Denmark)
- Ajinomoto Co., Inc. (Japan)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Immunity Nutraceutical Ingredient Market Size (2021-2032)
- 2.2.2 Global Immunity Nutraceutical Ingredient Sales (2021-2032)
- 2.2.3 Global Immunity Nutraceutical Ingredient Market Average Price (2021-2032)
- 2.3 Immunity Nutraceutical Ingredient by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Carotenoids
- 2.3.3 Minerals
- 2.3.4 Omega-3 fatty acids
- 2.3.5 Fibers & specialty carbohydrates
- 2.3.6 Phytochemical and plant extracts
- 2.3.7 Others
- 2.4 Immunity Nutraceutical Ingredient by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dietary supplements
- 2.4.3 Functional beverages
- 2.4.4 Functional food
- 2.4.5 Personal care
- 2.4.6 Animal nutrition
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Immunity Nutraceutical Ingredient Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Immunity Nutraceutical Ingredient Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Immunity Nutraceutical Ingredient Revenue of Manufacturers (2021-2026)
- 3.4 Global Immunity Nutraceutical Ingredient Average Price by Manufacturers (2021-2026)
- 3.5 Global Immunity Nutraceutical Ingredient Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Immunity Nutraceutical Ingredient, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Immunity Nutraceutical Ingredient, Product Type & Application
- 3.8 Global Manufacturers of Immunity Nutraceutical Ingredient, Established Date
- 3.9 Global Immunity Nutraceutical Ingredient Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Tate & Lyle PLC (U.K)
- 4.1.1 Tate & Lyle PLC (U.K) Company Information
- 4.1.2 Tate & Lyle PLC (U.K) Business Overview
- 4.1.3 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Portfolio
- 4.1.5 Tate & Lyle PLC (U.K) Recent Developments
- 4.2 Koninklijke DSM N.V. (Netherlands)
- 4.2.1 Koninklijke DSM N.V. (Netherlands) Company Information
- 4.2.2 Koninklijke DSM N.V. (Netherlands) Business Overview
- 4.2.3 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Portfolio
- 4.2.5 Koninklijke DSM N.V. (Netherlands) Recent Developments
- 4.3 Ingredion Incorporated (U.S)
- 4.3.1 Ingredion Incorporated (U.S) Company Information
- 4.3.2 Ingredion Incorporated (U.S) Business Overview
- 4.3.3 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Portfolio
- 4.3.5 Ingredion Incorporated (U.S) Recent Developments
- 4.4 Arla Foods (Denmark)
- 4.4.1 Arla Foods (Denmark) Company Information
- 4.4.2 Arla Foods (Denmark) Business Overview
- 4.4.3 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Portfolio
- 4.4.5 Arla Foods (Denmark) Recent Developments
- 4.5 Ajinomoto Co., Inc. (Japan)
- 4.5.1 Ajinomoto Co., Inc. (Japan) Company Information
- 4.5.2 Ajinomoto Co., Inc. (Japan) Business Overview
- 4.5.3 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Portfolio
- 4.5.5 Ajinomoto Co., Inc. (Japan) Recent Developments
5 Global Immunity Nutraceutical Ingredient Market Scenario by Region
- 5.1 Global Immunity Nutraceutical Ingredient Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Immunity Nutraceutical Ingredient Sales by Region: 2021-2032
- 5.2.1 Global Immunity Nutraceutical Ingredient Sales by Region: 2021-2026
- 5.2.2 Global Immunity Nutraceutical Ingredient Sales by Region: 2027-2032
- 5.3 Global Immunity Nutraceutical Ingredient Revenue by Region: 2021-2032
- 5.3.1 Global Immunity Nutraceutical Ingredient Revenue by Region: 2021-2026
- 5.3.2 Global Immunity Nutraceutical Ingredient Revenue by Region: 2027-2032
- 5.4 North America Immunity Nutraceutical Ingredient Market Facts & Figures by Country
- 5.4.1 North America Immunity Nutraceutical Ingredient Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
- 5.4.3 North America Immunity Nutraceutical Ingredient Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Immunity Nutraceutical Ingredient Market Facts & Figures by Country
- 5.5.1 Europe Immunity Nutraceutical Ingredient Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
- 5.5.3 Europe Immunity Nutraceutical Ingredient Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Immunity Nutraceutical Ingredient Market Facts & Figures by Country
- 5.6.1 Asia Pacific Immunity Nutraceutical Ingredient Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Immunity Nutraceutical Ingredient Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Immunity Nutraceutical Ingredient Market Facts & Figures by Country
- 5.7.1 South America Immunity Nutraceutical Ingredient Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
- 5.7.3 South America Immunity Nutraceutical Ingredient Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Immunity Nutraceutical Ingredient Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Immunity Nutraceutical Ingredient Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Immunity Nutraceutical Ingredient Sales by Type (2021-2032)
- 6.1.1 Global Immunity Nutraceutical Ingredient Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Immunity Nutraceutical Ingredient Sales Market Share by Type (2021-2032)
- 6.2 Global Immunity Nutraceutical Ingredient Revenue by Type (2021-2032)
- 6.2.1 Global Immunity Nutraceutical Ingredient Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2021-2032)
- 6.3 Global Immunity Nutraceutical Ingredient Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Immunity Nutraceutical Ingredient Sales by Application (2021-2032)
- 7.1.1 Global Immunity Nutraceutical Ingredient Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Immunity Nutraceutical Ingredient Sales Market Share by Application (2021-2032)
- 7.2 Global Immunity Nutraceutical Ingredient Revenue by Application (2021-2032)
- 7.2.1 Global Immunity Nutraceutical Ingredient Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2021-2032)
- 7.3 Global Immunity Nutraceutical Ingredient Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Immunity Nutraceutical Ingredient Value Chain Analysis
- 8.1.1 Immunity Nutraceutical Ingredient Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Immunity Nutraceutical Ingredient Production Mode & Process
- 8.2 Immunity Nutraceutical Ingredient Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Immunity Nutraceutical Ingredient Distributors
- 8.2.3 Immunity Nutraceutical Ingredient Customers
9 Global Immunity Nutraceutical Ingredient Analyzing Market Dynamics
- 9.1 Immunity Nutraceutical Ingredient Industry Trends
- 9.2 Immunity Nutraceutical Ingredient Industry Drivers
- 9.3 Immunity Nutraceutical Ingredient Industry Opportunities and Challenges
- 9.4 Immunity Nutraceutical Ingredient Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst